Low-dose erythropoietin in anemic arthroplasty patients within contemporary patient blood management pathways

Key Points

• This research aims to evaluate the effect of low-dose erythropoietin on hemoglobin levels in anemic patients undergoing arthroplasty within a patient blood management framework.
• Utilized low-dose preoperative erythropoietin administration
• Assessed hemoglobin levels perioperatively
• Monitored transfusion events during the surgical process
• Significantly improved perioperative hemoglobin levels
• Achieved a transfusion-free perioperative course
• Effective in patients with higher baseline hematologic risk